Unlock next-gen skin, hair, and tissue repairguided by Valley Weight Loss science and support.
There is no upper limit (UL) because toxicity due to high dosage is unlikely
New peptide drugs are being developed for more effective treatments, with over 100 already approved by the FDA, highlighting their well-researched and regulated nature
Each success story is a testament to the therapys ability to deliver real, measurable benefits
The FDA has also flagged BPC-157 as a bulk drug substance that may present significant safety risks when used in compounding, noting limited safety information and concerns like immunogenicity for certain routes of administration and peptide-related impurities
The peptides oral bioavailability is low (58%), but it accumulates preferentially in inflamed colonic tissue, making systemic absorption less critical